Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Heart Test Laboratories, Inc. - Common Stock (NQ: HSCS ) 4.390 -0.290 (-6.20%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 45,968 Open 4.590 Bid (Size) 4.220 (1) Ask (Size) 4.690 (1) Prev. Close 4.680 Today's Range 4.210 - 4.590 52wk Range 2.360 - 52.00 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket September 24, 2024 Via Benzinga HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results September 12, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire Performance YTD -73.74% -73.74% 1 Month +35.91% +35.91% 3 Month -7.58% -7.58% 6 Month -58.47% -58.47% 1 Year -89.79% -89.79% More News Read More HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission September 12, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire Recap: Heart Test Laboratories Q3 Earnings March 14, 2024 Via Benzinga HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results July 29, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency July 26, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare July 25, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction July 11, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 05, 2024 Via Benzinga HeartSciences Regains Compliance with Nasdaq Listing Requirements June 04, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session May 31, 2024 Via Benzinga HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio May 20, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire Why Cracker Barrel Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 17, 2024 Via Benzinga US Stocks Edge Higher; Applied Materials Posts Upbeat Earnings May 17, 2024 Via Benzinga Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session May 13, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday May 13, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session April 25, 2024 Via Benzinga HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG April 24, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences to Present at the LD Micro Invitational XIV Conference April 02, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients March 26, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire HSCS Stock Earnings: Heart Test Laboratories Beats EPS for Q3 2024 March 14, 2024 Via InvestorPlace HeartSciences Reports Third Quarter Fiscal 2024 Financial Results March 14, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes March 12, 2024 From Heart Test Laboratories, Inc. Via GlobeNewswire Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 06, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
